These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38445623)

  • 1. Factors Influencing the Risk of No-Reflow Development.
    Kanal Y
    Anatol J Cardiol; 2024 Mar; 28(5):255-6. PubMed ID: 38445623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influencing factor analysis of no-reflow phenomenon after reperfusion in patients with chronic limb ischemia associated with acute thrombosis].
    Hao Y; Ren W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Mar; 26(3):336-40. PubMed ID: 22506474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.
    Diao Y; Yin M; Zhang B; Sun B
    Bioengineered; 2021 Dec; 12(1):8614-8621. PubMed ID: 34612772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score.
    Dawson LP; Rashid M; Dinh DT; Brennan A; Bloom JE; Biswas S; Lefkovits J; Shaw JA; Chan W; Clark DJ; Oqueli E; Hiew C; Freeman M; Taylor AJ; Reid CM; Ajani AE; Kaye DM; Mamas MA; Stub D;
    Circ Cardiovasc Interv; 2024 Apr; 17(4):e013738. PubMed ID: 38487882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI.
    Dogan NB; Ozpelit E; Akdeniz S; Bilgin M; Baris N
    Pak J Med Sci; 2015; 31(3):576-81. PubMed ID: 26150847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.
    Iwakura K; Ito H; Kawano S; Shintani Y; Yamamoto K; Kato A; Ikushima M; Tanaka K; Kitakaze M; Hori M; Higashino Y; Fujii K
    J Am Coll Cardiol; 2001 Aug; 38(2):472-7. PubMed ID: 11499740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Yang L; Cong H; Lu Y; Chen X; Liu Y
    Medicine (Baltimore); 2020 Jun; 99(26):e20152. PubMed ID: 32590726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for No-Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
    Liang T; Liu M; Wu C; Zhang Q; Lu L; Wang Z
    Rev Invest Clin; 2017; 69(3):139-145. PubMed ID: 28613283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
    Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
    Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications.
    Ahn SJ; Park KH; Ryoo NK; Hong JH; Jung C; Yoon CH; Han MK; Woo SJ
    PLoS One; 2015; 10(11):e0142852. PubMed ID: 26599539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No reflow phenomenon in CAD patients after percutaneous coronary intervention: A prospective hospital based observational study.
    Rao S; Bhardwaj R; Negi PC; Nath RK
    Indian Heart J; 2023; 75(2):156-159. PubMed ID: 36781051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of individual susceptibility to the no-reflow phenomenon after acute myocardial infarction.
    Iwakura K
    Curr Pharm Des; 2013; 19(25):4519-28. PubMed ID: 23270556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plateletcrit may predict no-reflow after saphenous vein graft interventions in patients with non-ST elevation myocardial infarction.
    Panç C; Derviş E; Gürbak İ
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):194-199. PubMed ID: 33560004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Tasar O; Karabay AK; Oduncu V; Kirma C
    Coron Artery Dis; 2019 Jun; 30(4):270-276. PubMed ID: 31026233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients.
    Bayramoğlu A; Taşolar H; Kaya A; Tanboğa İH; Yaman M; Bektaş O; Günaydın ZY; Oduncu V
    J Interv Cardiol; 2018 Apr; 31(2):144-149. PubMed ID: 29193382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI.
    Li H; Fu DG; Liu FY; Zhou H; Li XM
    Exp Ther Med; 2018 Apr; 15(4):3940-3946. PubMed ID: 29563988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple and rapid method for identification of lesions at high risk for the no-reflow phenomenon immediately before elective coronary stent implantation.
    Suda A; Namiuchi S; Kawaguchi T; Nihei T; Takii T; Saji K; Sugie T; Kato A; Shimokawa H
    Heart Vessels; 2016 Dec; 31(12):1904-1914. PubMed ID: 26936449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of pre-primary percutaneous coronary intervention β blocker use on the no-reflow phenomenon in patients with acute myocardial infarction].
    Wang J; Chen Y; Wang C; Zhu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):822-6. PubMed ID: 25547444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Letter to the Editor: 'Factors Influencing the Risk of No-Reflow Development'.
    Çelik İE; Yarlıoğlu M; Barutcu O; Akgün O; Duran M; Yorulmaz Ş; Öztürk S; Murat SN
    Anatol J Cardiol; 2024 Mar; 28(5):257-61. PubMed ID: 38430116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.